AFAP1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.947800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.175800E-01
Normal-vs-Stage2
6.652600E-01
Normal-vs-Stage3
6.031000E-01
Normal-vs-Stage4
6.357800E-01
Stage1-vs-Stage2
1.262370E-01
Stage1-vs-Stage3
9.878000E-01
Stage1-vs-Stage4
1.469020E-01
Stage2-vs-Stage3
2.158600E-01
Stage2-vs-Stage4
8.997000E-01
Stage3-vs-Stage4
2.255600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.291600E-01
Normal-vs-AfricanAmerican
7.926600E-01
Normal-vs-Asian
8.694200E-01
Caucasian-vs-AfricanAmerican
9.662800E-01
Caucasian-vs-Asian
9.404400E-01
AfricanAmerican-vs-Asian
9.244200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.407800E-01
Normal-vs-Female
7.424600E-01
Male-vs-Female
6.020200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.475600E-01
Normal-vs-Age(41-60Yrs)
4.430800E-01
Normal-vs-Age(61-80Yrs)
9.708400E-01
Normal-vs-Age(81-100Yrs)
9.838200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.758960E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.047800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.112000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.638500E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.455770E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.069200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.330400E-01
Normal-vs-Daily Drinker
7.695200E-01
Normal-vs-Weekly Drinker
9.132600E-01
Normal-vs-Occasional Drinker
6.195600E-01
Normal-vs-Social Drinker
5.043400E-01
Non Drinker-vs-Daily Drinker
4.325800E-01
Non Drinker-vs-Weekly Drinker
9.785800E-01
Non Drinker-vs-Occasional Drinker
3.194200E-01
Non Drinker-vs-Social Drinker
1.801610E-01
Daily Drinker-vs-Weekly Drinker
4.508200E-01
Daily Drinker-vs-Occasional Drinker
1.098570E-01
Daily Drinker-vs-Social Drinker
5.418100E-02
Weekly Drinker-vs-Occasional Drinker
4.057200E-01
Weekly Drinker-vs-Social Drinker
2.478200E-01
Occasional Drinker-vs-Social Drinker
7.504400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.528000E-01
Normal-vs-Grade 2
1.743990E-01
Normal-vs-Grade 3
2.159000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.281930E-02
Grade 1-vs-Grade 3
7.458500E-03
Grade 1-vs-Grade 4
6.528000E-01
Grade 2-vs-Grade 3
1.893240E-01
Grade 2-vs-Grade 4
1.743990E-01
Grade 3-vs-Grade 4
2.159000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.357400E-01
Normal-vs-NonDiabetic
8.248600E-01
Diabetic-vs-NonDiabetic
9.673200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.076800E-01
Normal-vs-NoPancreatitis
8.397600E-01
Pancreatitis-vs-NoPancreatitis
2.934000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.826800E-01
Normal-vs-N1
6.734200E-01
N0-vs-N1
1.229430E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.644600E-01
Normal-vs-TP53-NonMutant
6.713200E-01
TP53-Mutant-vs-TP53-NonMutant
7.205800E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
